Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP665057.RAKsGrHiSPip8Dak2USYCROhB9o-dgGTQH3AT3FXq1iYc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP665057.RAKsGrHiSPip8Dak2USYCROhB9o-dgGTQH3AT3FXq1iYc130_assertion type Assertion NP665057.RAKsGrHiSPip8Dak2USYCROhB9o-dgGTQH3AT3FXq1iYc130_head.
- NP665057.RAKsGrHiSPip8Dak2USYCROhB9o-dgGTQH3AT3FXq1iYc130_assertion description "[This study used a case-control design to assess the predictive value of 3 polymorphisms in VDR (TaqI and FokI) and HER-2 (Val655Ile) to determine the risk of developing PRCa in patients with BPH.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP665057.RAKsGrHiSPip8Dak2USYCROhB9o-dgGTQH3AT3FXq1iYc130_provenance.
- NP665057.RAKsGrHiSPip8Dak2USYCROhB9o-dgGTQH3AT3FXq1iYc130_assertion evidence source_evidence_literature NP665057.RAKsGrHiSPip8Dak2USYCROhB9o-dgGTQH3AT3FXq1iYc130_provenance.
- NP665057.RAKsGrHiSPip8Dak2USYCROhB9o-dgGTQH3AT3FXq1iYc130_assertion SIO_000772 15083213 NP665057.RAKsGrHiSPip8Dak2USYCROhB9o-dgGTQH3AT3FXq1iYc130_provenance.
- NP665057.RAKsGrHiSPip8Dak2USYCROhB9o-dgGTQH3AT3FXq1iYc130_assertion wasDerivedFrom befree-20140225 NP665057.RAKsGrHiSPip8Dak2USYCROhB9o-dgGTQH3AT3FXq1iYc130_provenance.
- NP665057.RAKsGrHiSPip8Dak2USYCROhB9o-dgGTQH3AT3FXq1iYc130_assertion wasGeneratedBy ECO_0000203 NP665057.RAKsGrHiSPip8Dak2USYCROhB9o-dgGTQH3AT3FXq1iYc130_provenance.